Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HCV Recurrence After Liver Transplantation”

26 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 26 results

Not applicableUnknownNCT01944527
What this trial is testing

Use of Direct-acting Antiviral to Treat HCV Recurrence After Liver Transplantation (ANRSCO23CUPILT) Infection

Who this might be right for
HCV RecurrenceLiver TransplantationDirect-acting Antiviral Agents
ANRS, Emerging Infectious Diseases 699
Large-scale testing (Phase 3)Ended earlyNCT02478229
What this trial is testing

Early Treatment With Sofosbuvir (SOF) and Ledipasvir (LDV) to Prevent HCV Recurrence After Liver Transplantation (OLT)

Who this might be right for
Hepatitis C Viral Infection
University Health Network, Toronto 1
Not applicableStudy completedNCT03665766
What this trial is testing

Effect of Cyclosporine A Versus Tacrolimus on Response to Antiviral Therapy After Hepatitis C Genotype -4 Recurrence Post Liver Transplantation

Who this might be right for
Liver Transplantation
Ain Shams University 126
Not applicableStudy completedNCT00710801
What this trial is testing

Assessment of Biomarkers for Recurrent HCV Infection Post-liver Transplantation

Who this might be right for
Hepatitis C Virus
University of Alberta 40
Not applicableStudy completedNCT02209675
What this trial is testing

Role of Tissue C4d in Differentiation Between Acut e Rejection and HCV Recurrence After Liver Transplantation

Who this might be right for
Liver Disease
Ain Shams University 25
Not applicableUnknownNCT00213707
What this trial is testing

Study of the Role of Dendritic Cells in the Recurrence of Hepatitis C After Liver Transplantation. Analysis of Hepatitis C Virus (HCV) Quasispecies Evolution.

Who this might be right for
HCV Infection
University Hospital, Strasbourg, France 30
Large-scale testing (Phase 3)Study completedNCT00469131
What this trial is testing

Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + Steroid

Who this might be right for
Hepatitis CLiver Cirrhosis
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 79
Testing effectiveness (Phase 2)Ended earlyNCT01535092
What this trial is testing

Legalon SIL for the Treatment of HCV Recurrence in Liver Transplanted Patients

Who this might be right for
HCV Recurrence After Liver Transplantation
Rottapharm 14
Testing effectiveness (Phase 2)Study completedNCT01938625
What this trial is testing

Pharmacokinetics, Efficacy, Safety, Tolerability, of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052), and Ribavirin (RBV) in Patients With Recurrent Chronic Hepatitis C Genotype 1b Infection After Orthotopic Liver Transplantation

Who this might be right for
Hepatitis C, Chronic
Janssen R&D Ireland 35
Large-scale testing (Phase 3)Ended earlyNCT00375895
What this trial is testing

Switch From Tacrolimus to Cyclosporin in the Treatment of Recurrent Hepatitis C After Liver Transplantation

Who this might be right for
Chronic Hepatitis CEvidence of Liver Transplantation
Rennes University Hospital 11
Large-scale testing (Phase 3)Study completedNCT00151580
What this trial is testing

Treatment of Recurrent Hepatitis C After Liver Transplantation

Who this might be right for
Liver TransplantationHepatitis C
Rennes University Hospital 200
Early research (Phase 1)Study completedNCT01074203
What this trial is testing

A Pilot Study to Examine the Role of Nitazoxanide to Prevent Recurrence of Hepatitis C After Transplantation

Who this might be right for
Hepatitis C Recurrence
Mayo Clinic 8
Testing effectiveness (Phase 2)Study completedNCT00135798
What this trial is testing

Pre-Transplant Treatment to Prevent Recurrence of Hepatitis C After Liver Transplantation

Who this might be right for
Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 79
Large-scale testing (Phase 3)Study completedNCT01707849
What this trial is testing

The Impact of Everolimus Based Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver Transplantation

Who this might be right for
Hepatitis C Recurrence After Liver Transplant
Hospital Vall d'Hebron 18
Large-scale testing (Phase 3)Study completedNCT00378599
What this trial is testing

Effects of Pegylated Interferon Alfa-2b and Ribavirin After Orthotopic Liver Transplantation in Subjects With Chronic Hepatitis C Recurrence (P04590AM3)(COMPLETED)

Who this might be right for
Liver TransplantationHepatitis C, ChronicLiver Cirrhosis
Merck Sharp & Dohme LLC 125
Testing effectiveness (Phase 2)Study completedNCT01559844
What this trial is testing

Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant

Who this might be right for
Hepatitis CHepatocellular Carcinoma
Gilead Sciences 61
Post-approval studies (Phase 4)Study completedNCT03133065
What this trial is testing

Early Treatment of Recurrent HCV- Infection Post Liver Transplantation in the Era of DAAs

Who this might be right for
Liver Transplantation
Ain Shams University 89
Testing effectiveness (Phase 2)Study completedNCT02165189
What this trial is testing

An Efficacy and Safety Study of Simeprevir and Sofosbuvir With and Without Ribavirin in Participants With Recurrent Genotype 1 Hepatitis C Post-Orthotopic Liver Transplant

Who this might be right for
Hepatitits C
Janssen Scientific Affairs, LLC 46
Testing effectiveness (Phase 2)Ended earlyNCT00582738
What this trial is testing

Efficacy of Everolimus as Inhibitor of Fibrosis Progression in Liver Transplant Patients With Recurrence of Hepatitis C Viral Infection

Who this might be right for
Recurrent Hepatitis C
Novartis Pharmaceuticals 43
Not applicableNo Longer AvailableNCT02161939
What this trial is testing

Treatment Protocol of Daclatasvir (BMS-790052) in Combination With Sofosbuvir for the Treatment of Post-Liver Transplant Subjects With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb
Load More Results